News for STERIS plc (STEN.MX)

Steris PLC (STE) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares curr

On March 3, 2025, Isomedix Operations, Inc., a subsidiary of STERIS plc (STE), announced that it has entered into binding confidential term sheets and settlem

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

Strengths: Market leadership in sterilization services and a robust product portfolio in infection prevention.Weaknesses: Potential financial impact from ongoi

Total Revenue Growth: 6% reported growth, 6% constant currency organic growth.Gross Margin: Increased by 90 basis points to 44.6%.EBIT Margin: Decreased by 10

Feb 06, 2025 / 02:00PM GMTOperator Good day and welcome to the Steris PLC third quarter 2025 conference call. (Operator Instructions) Please note this event is

STERIS plc (NYSE:STE) Q3 2025 Earnings Conference Call February 6, 2025 9:00 AM ETCompany ParticipantsJulie Winter – Investor RelationsMike Tokich – Senior...

**media[533463]**

**media[526713]**

**media[521990]**

Shares of Steris PLC (STE) surged 3.32% in mid-day trading on Jan 21. The stock reached an intraday high of $218.19, before settling at $216.58, up from its

Steris PLC (STE), a global leader in infection prevention and healthcare products, announced on January 21, 2025, that a jury trial involving its subsidiary, Is

DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (: STE) (”œSTERIS” or the ”œCompany”) today announced that a jury trial that had been ongo

Total Revenue Growth: 7% in the second quarter.Constant Currency Organic Revenue Growth: 7% in the quarter.Gross Margin: Decreased 50 basis points to 43.7%.EBI

Nov 07, 2024 / 02:00PM GMTOperator Good day, everybody, and welcome to the STERIS PLC second-quarter 2025 earnings call. (Operator Instructions) Please note, to

Strengths: Market leadership in infection prevention and sterilization services.Weaknesses: Potential risks associated with ongoing litigation and regulatory c

STERIS plc (NYSE:STE) Q2 2025 Results Conference Call November 7, 2024 9:00 AM ETCompany ParticipantsJulie Winter - Investor RelationsMike Tokich - Senior...

Steris Plc (STER, Financial) shares were down 4% today, despite the company's second-quarter adjusted EPS for fiscal 2025 rising by 15.1% to $2.14, which was 1.

Shares of Steris PLC (STE) fell 4.41% in mid-day trading on Nov 7. The stock reached an intraday low of $211.31, before recovering slightly to $217.50, down